Strategy

Photo
08.12.2021 • NewsStrategy

Chemistry Shapes the Future

In his interview with CHEManager, Jeff Zhu, chairman of the Chinese Association of International Chemical Manufacturers (AICM), talks about the industry’s role in helping achieve China’s carbon-neutrality goal.

Photo
03.12.2021 • NewsStrategy

Environmental Reform of China’s Chemical Industrial Parks

In the past 20 years, the chemical industry in China has grown rapidly and today accounts for close to 40% of worldwide chemical-industry revenue. Understanding environment-related regulatory and policy shifts now in full swing in China is critical to ensuring compliance and reducing business interruption risks for chemical companies either operating in or sourcing from China.

Photo
01.12.2021 • TopicsStrategy

Precision — Passion — Patience

The positive impacts of Predictive Maintenance are broad and should be considered holistically. No one ever said that nurturing a perfect rose garden was simple, but the results can be dramatic.

Photo
29.10.2021 • NewsStrategy

Short-Term Reshoring

The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030.

Photo
15.10.2021 • NewsStrategy

A Pivotal Move to Net-Zero

Leading global chemical companies and the World Economic Forum (WEF) have announced that they are entering an agreement to formalize the Low-Carbon Emitting Technologies (LCET) initiative into a stand-alone entity by the end of 2023, to share early-stage risks and co-invest in developing and upscaling low-carbon emitting technologies.

Photo
16.09.2021 • NewsStrategy

Managing Supply for Complex Biotherapeutics

Successfully managing the drug substance manufacturing of Antibody-Drug Conjugates (ADCs) requires a sophisticated understanding of the technological development process and access to a range of large- and small-molecule manufacturing assets.

Photo
15.09.2021 • NewsStrategy

Processes4Planet: EU Cross-Sectorial R&I

The Processes4Planet (P4Planet) partnership’s goal is to transform the European process industries to make them circular and achieve overall climate neutrality at EU level by 2050, while enhancing their global competitiveness.

Photo
07.09.2021 • NewsStrategy

A Roadmap for Pharma 4.0

Industry experts Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 group – talk about the idea behind ISPE’s Pharma 4.0 initiative and the challenges on the way to realize the digital transformation of the pharmaceutical industry.

Photo
09.08.2021 • NewsStrategy

The Future of Sustainability Policy

Over the past few years, sustainability has become a priority for innovation teams in the materials and chemicals industry as well as consumer-facing industries like apparel, food, and beauty.

Photo
28.06.2021 • NewsStrategy

Quantum Computing – A Truly Disruptive Force for Industries?

On June 10th, 2021, ten leading German corporations announced the foundation of the Quantum Technology and Application Consortium (QUTAC). Boosted by the German Government, the goal of the newly founded consortium is to further develop the existing fundamentals of quantum computing into usable industrial applications.

Photo
03.06.2021 • NewsStrategy

On the Way to Climate Neutrality

The EU Commission’s ambitious plan for a European Green Deal, launched shortly before the pandemic struck in early 2020, aims to make the continent the world’s first climate-neutral region by 2050. The goals spelled out in January last year call for reduction of greenhouse gas emissions by at least 50% up to 2030, compared with 1990 levels.

Photo
04.05.2021 • TopicsStrategy

The Role of Clean Hydrogen for a Climate Neutral Industry

Europe wants to become the world’s first climate-neutral continent by 2050 and decouple its economic growth from the consumption of natural resources – this is what the members of the European Union committed to in the so-called Green Deal in December 2019.

Photo
26.04.2021 • NewsStrategy

Covid-19 Driving Manufacturing, CDMOs Driving Growth

The CPhI executive post-pandemic pharma survey, produced by Informa Markets as part of the CPhI Pharma 2021 Report, predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next 5 years, governments and companies will gradually look to reduce complexity and increase regional self-reliance.

Photo
20.04.2021 • NewsStrategy

Swiss Biotech Report 2021

Switzerland, as one of the leading global biotech hubs, was well positioned to facilitate international collaborations and develop solutions to combat the Covid-19 pandemic, and the sector saw record levels of investment in 2020. This is the bottom line of the latest edition of the Swiss Biotech Report, published by the Swiss Biotech Association in conjunction with EY and eight other partner organizations.

Photo
13.03.2021 • NewsStrategy

Renewable Hydrogen

To take advantage of the opportunity hydrogen presents, the European chemical industry must engage in the emerging hydrogen market now, setting up specific pilots, develop an appropriate partner and ecosystem network and, most crucially, adapt the R&D portfolios and investment plans needed to capture a share of the hydrogen opportunity.

453 more articles

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.